Home / Latest Reports / Prenatal Dna Sequencing Market

Prenatal DNA Sequencing Market by Application- Global Industry Analysis & Forecast to 2027

Published On : October 2020 Pages : 136 Category: Biotechnology Report Code : HC1113437

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Prenatal DNA Sequencing Market By Application (Hemophilia, DiGeorge Syndrome, Cystic Fibrosis, Down Syndrome, Autism, Cancer, AIDS, Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Prenatal DNA Sequencing Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Prenatal DNA Sequencing is commonly used to screen fetal disorders resulting from an extra chromosome, Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome) and Trisomy 13 (Patau syndrome). It also has been used to detect conditions resulting from an extra sex chromosome, from a missing part of a chromosome.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Prenatal DNA Sequencing Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Laboratory Corporation of America
  • Natera
  • Genomic Health
  • Myriad Genetics
  • Invitae
  • BGI
  • Illumina.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Prenatal DNA Sequencing Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Hemophilia

o    DiGeorge Syndrome

o    Cystic Fibrosis

o    Down Syndrome

o    Autism

o    Cancer

o    AIDS

o    Others

·         Prenatal DNA Sequencing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Agilent Technologies

o    F. Hoffmann-La Roche

o    Laboratory Corporation of America

o    Natera

o    Genomic Health

o    Myriad Genetics

o    Invitae

o    BGI

o    Illumina

·         Prenatal DNA Sequencing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Prenatal DNA Sequencing Market, By Country

o    U.S. Prenatal DNA Sequencing Market

o    Canada Prenatal DNA Sequencing Market

o    Mexico Prenatal DNA Sequencing Market

o    Europe

§  Europe Prenatal DNA Sequencing Market, By Country

o    UK Prenatal DNA Sequencing Market

o    Germany Prenatal DNA Sequencing Market

o    France Prenatal DNA Sequencing Market

o    Russia Prenatal DNA Sequencing Market

o    Italy Prenatal DNA Sequencing Market

o    Rest of Europe Prenatal DNA Sequencing Market

o    Asia-Pacific

§  Asia-Pacific Prenatal DNA Sequencing Market, By Country

o    China Prenatal DNA Sequencing Market

o    Japan Prenatal DNA Sequencing Market

o    South Korea Prenatal DNA Sequencing Market

o    India Prenatal DNA Sequencing Market

o    Southeast Asia Prenatal DNA Sequencing Market

o    Rest of Asia-Pacific Prenatal DNA Sequencing Market

o    South America

§  South America Prenatal DNA Sequencing Market

o    Brazil Prenatal DNA Sequencing Market

o    Argentina Prenatal DNA Sequencing Market

o    Columbia Prenatal DNA Sequencing Market

o    Rest of South America Prenatal DNA Sequencing Market

o    Middle East and Africa

§  Middle East and Africa Prenatal DNA Sequencing Market

o    Saudi Arabia Prenatal DNA Sequencing Market

o    UAE Prenatal DNA Sequencing Market

o    Egypt Prenatal DNA Sequencing Market

o    Nigeria Prenatal DNA Sequencing Market

o    South Africa Prenatal DNA Sequencing Market

o    TurkeyPrenatal DNA Sequencing Market

o    Rest of MEA Prenatal DNA Sequencing Market 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Prenatal DNA Sequencing  Market, By Applications

5.1.     Introduction

5.2.     Global Prenatal DNA Sequencing  Revenue and Market Share by Applications (2017-2021)

5.2.1.  Global Prenatal DNA Sequencing  Revenue and Revenue Share by Applications (2017-2021)

5.3.     Hemophilia

5.3.1.  Global Hemophilia Revenue and Growth Rate (2017-2021)

5.4.     DiGeorge Syndrome

5.4.1.  Global DiGeorge Syndrome Revenue and Growth Rate (2017-2021)

5.5.     Cystic Fibrosis

5.5.1.  Global Cystic Fibrosis Revenue and Growth Rate (2017-2021)

5.6.     Down Syndrome

5.6.1.  Global Down Syndrome Revenue and Growth Rate (2017-2021)

5.7.     Autism

5.7.1.  Global Autism Revenue and Growth Rate (2017-2021)

5.8.     Cancer

5.8.1.  Global Cancer Revenue and Growth Rate (2017-2021)

5.9.     AIDS

5.9.1.  Global AIDS Revenue and Growth Rate (2017-2021)

5.10. Others

5.10.1.      Global Others Revenue and Growth Rate (2017-2021)

6.       Prenatal DNA Sequencing  Market, By Region

6.1.     Introduction

6.2.     Global Prenatal DNA Sequencing  Revenue and Market Share by Regions

6.2.1.  Global Prenatal DNA Sequencing  Revenue by Regions (2017-2021)

6.3.     North America Prenatal DNA Sequencing  by Countries

6.3.1.  North America Prenatal DNA Sequencing  Revenue and Growth Rate (2017-2021)

6.3.2.  North America Prenatal DNA Sequencing  Revenue (Million USD) by Countries (2017-2021)

6.3.3.  United States

6.3.3.1.  United States Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.3.4.  Canada

6.3.4.1.  Canada Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.3.5.  Mexico

6.3.5.1.  Mexico Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.4.     Europe Prenatal DNA Sequencing  by Countries

6.4.1.  Europe Prenatal DNA Sequencing  Revenue and Growth Rate (2017-2021)

6.4.2.  Europe Prenatal DNA Sequencing  Revenue (Million USD) by Countries (2017-2021)

6.4.3.  Germany

6.4.3.1.  Germany Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.4.4.  France

6.4.4.1.  France Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.4.5.  UK

6.4.5.1.  UK Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.4.6.  Russia

6.4.6.1.  Russia Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.4.7.  Italy

6.4.7.1.  Italy Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.5.     Asia-Pacific Prenatal DNA Sequencing  by Countries

6.5.1.  Asia-Pacific Prenatal DNA Sequencing  Revenue and Growth Rate (2017-2021)

6.5.2.  Asia-Pacific Prenatal DNA Sequencing  Revenue (Million USD) by Countries (2017-2021)

6.5.3.  China

6.5.3.1.  China Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.5.4.  Japan

6.5.4.1.  Japan Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.5.5.  Korea

6.5.5.1.  Korea Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.5.6.  India

6.5.6.1.  India Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.6.     South America Prenatal DNA Sequencing  by Countries

6.6.1.  South America Prenatal DNA Sequencing  Revenue and Growth Rate (2017-2021)

6.6.2.  South America Prenatal DNA Sequencing  Revenue (Million USD) by Countries (2017-2021)

6.6.3.  Brazil

6.6.3.1.  Brazil Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.6.4.  Argentina

6.6.4.1.  Argentina Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.6.5.  Columbia

6.6.5.1.  Columbia Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.     Middle East and Africa Prenatal DNA Sequencing  by Countries

6.7.1.  Middle East and Africa Prenatal DNA Sequencing  Revenue and Growth Rate (2017-2021)

6.7.2.  Middle East and Africa Prenatal DNA Sequencing  Revenue (Million USD) by Countries (2017-2021)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.5.  Egypt

6.7.5.1.  Egypt Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.6.  Nigeria

6.7.6.1.  Nigeria Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.7.  South Africa

6.7.7.1.  South Africa Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.8.  Turkey

6.7.8.1.  Turkey Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.       Company Profiles

7.1.     Agilent Technologies

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     F. Hoffmann-La Roche

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     Laboratory Corporation of America

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Natera

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Genomic Health

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     Myriad Genetics

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     Invitae

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     BGI

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

7.9.     Illumina

7.9.1.  Business Overview

7.9.2.   Service Portfolio

7.9.3.  Strategic Developments

7.9.4.  Financial Overview

8.       Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.1.     Global Prenatal DNA Sequencing  Revenue (Millions USD) and Growth Rate (2022-2027)

8.2.     Prenatal DNA Sequencing  Market Forecast by Regions (2022-2027)

8.2.1.  North America Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.1.1.  United States Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.1.2.  Canada Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.1.3.  Mexico Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.  Europe Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.1.  Germany Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.2.  France Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.3.  UK Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.4.  Russia Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.5.  Italy Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.2.6.  Rest of Europe Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.  Asia-Pacific Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.1.  China Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.2.  Japan Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.3.  Korea Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.4.  India Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.5.  Southeast Asia Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.3.6.  Rest of Asia-Pacific Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.4.  South America Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.4.1.  Brazil Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.4.2.  Argentina Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.4.3.  Columbia Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.4.4.  Rest of South America Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.  Middle East and Africa Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.1.  Saudi Arabia Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.2.  United Arab Emirates Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.3.  Egypt Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.4.  Nigeria Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.5.  South Africa Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.6.  Turkey Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.2.5.7.  Rest of Middle East and Africa Prenatal DNA Sequencing  Market Forecast (2022-2027)

8.3.     Prenatal DNA Sequencing  Market Forecast by Applications (2022-2027)

8.3.1.  Prenatal DNA Sequencing  Forecast by Applications (2022-2027)

8.3.2.  Prenatal DNA Sequencing  Market Share Forecast by Applications (2022-2027)

List of Tables

List of Tables and Figures:

Figure United States Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Prenatal DNA Sequencing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Prenatal DNA Sequencing Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hemophilia Revenue and Growth Rate (2017-2019)
Figure Global DiGeorge Syndrome Revenue and Growth Rate (2017-2019)
Figure Global Cystic Fibrosis Revenue and Growth Rate (2017-2019)
Figure Global Down Syndrome Revenue and Growth Rate (2017-2019)
Figure Global Autism Revenue and Growth Rate (2017-2019)
Figure Global Cancer Revenue and Growth Rate (2017-2019)
Figure Global AIDS Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Prenatal DNA Sequencing Revenue by Regions (2017-2019)
Figure North America Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure North America Prenatal DNA Sequencing Revenue and Growth Rate (2017-2019)
Figure North America Prenatal DNA Sequencing by Countries (2017-2019)
Figure North America Prenatal DNA Sequencing Revenue (Million USD) by Countries (2017-2019)
Figure United States Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure United States Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Canada Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Mexico Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Europe Prenatal DNA Sequencing Revenue and Growth Rate (2017-2019)
Figure Europe Prenatal DNA Sequencing by Countries (2017-2019)
Figure Europe Prenatal DNA Sequencing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Germany Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure France Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure UK Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Russia Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Italy Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Rest of Europe Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Asia-Pacific Prenatal DNA Sequencing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Prenatal DNA Sequencing by Countries (2017-2019)
Figure Asia-Pacific Prenatal DNA Sequencing Revenue (Million USD) by Countries (2017-2019)
Figure China Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure China Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Japan Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Korea Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure India Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Southeast Asia Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure South America Prenatal DNA Sequencing Revenue and Growth Rate (2017-2019)
Figure South America Prenatal DNA Sequencing by Countries (2017-2019)
Figure South America Prenatal DNA Sequencing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Brazil Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Argentina Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Columbia Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Rest of South America Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Middle East and Africa Prenatal DNA Sequencing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Prenatal DNA Sequencing by Countries (2017-2019)
Figure Middle East and Africa Prenatal DNA Sequencing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Saudi Arabia Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure United Arab Emirates Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Egypt Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Nigeria Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure South Africa Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Turkey Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Prenatal DNA Sequencing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Agilent Technologies Prenatal DNA Sequencing Financial Overview
Table F. Hoffmann-La Roche Prenatal DNA Sequencing Financial Overview
Table Laboratory Corporation of America Prenatal DNA Sequencing Financial Overview
Table Natera Prenatal DNA Sequencing Financial Overview
Table Genomic Health Prenatal DNA Sequencing Financial Overview
Table Myriad Genetics Prenatal DNA Sequencing Financial Overview
Table Invitae Prenatal DNA Sequencing Financial Overview
Table BGI Prenatal DNA Sequencing Financial Overview
Table Illumina Prenatal DNA Sequencing Financial Overview
Figure Global Prenatal DNA Sequencing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Prenatal DNA Sequencing Market Forecast by Regions (2019-2027)
Figure North America Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure United States Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Canada Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Mexico Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Europe Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Germany Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure France Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure UK Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Russia Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Italy Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Rest of Europe Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Asia-Pacific Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure China Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Japan Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Korea Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure India Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Southeast Asia Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure South America Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Brazil Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Argentina Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Columbia Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Rest of South America Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Middle East and Africa Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Saudi Arabia Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure United Arab Emirates Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Egypt Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Nigeria Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure South Africa Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Turkey Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Prenatal DNA Sequencing Market Forecast (2019-2027)
Figure Global Prenatal DNA Sequencing Forecast by Applications (2019-2027)
Figure Global Prenatal DNA Sequencing Market Share Forecast by Applications (2019-2027)
Figure Global Prenatal DNA Sequencing Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample